Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 2416056)

1.

A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.

Crum R, Szabo S, Folkman J.

Science. 1985 Dec 20;230(4732):1375-8.

PMID:
2416056
2.

Control of angiogenesis with synthetic heparin substitutes.

Folkman J, Weisz PB, Joullié MM, Li WW, Ewing WR.

Science. 1989 Mar 17;243(4897):1490-3.

PMID:
2467380
3.

Angiostatic steroids. Method of discovery and mechanism of action.

Folkman J, Ingber DE.

Ann Surg. 1987 Sep;206(3):374-83. Review.

4.

Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.

Sakamoto N, Tanaka NG.

Invasion Metastasis. 1987;7(4):208-16.

PMID:
2444551
5.

Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.

McNatt LG, Weimer L, Yanni J, Clark AF.

J Ocul Pharmacol Ther. 1999 Oct;15(5):413-23.

PMID:
10530702
6.

Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.

Chen NT, Corey EJ, Folkman J.

Lab Invest. 1988 Oct;59(4):453-9.

PMID:
2459497
7.

Inhibition of angiogenesis by suramin.

Gagliardi A, Hadd H, Collins DC.

Cancer Res. 1992 Sep 15;52(18):5073-5.

8.

Inhibition of angiogenesis by aurintricarboxylic acid.

Gagliardi AR, Collins DC.

Anticancer Res. 1994 Mar-Apr;14(2A):475-9.

PMID:
7517120
9.
10.

Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S.

Science. 1983 Aug 19;221(4612):719-25.

PMID:
6192498
11.

Inhibition of angiogenesis through modulation of collagen metabolism.

Ingber D, Folkman J.

Lab Invest. 1988 Jul;59(1):44-51.

PMID:
2455830
12.

Anti-tumor and anti-angiogenic effects in mice of heparin conjugated to angiostatic steroids.

Derbyshire EJ, Comin GA, Yang YC, Overholser J, Watkins L, Thorpe PE.

Int J Cancer. 1995 Nov 27;63(5):694-701.

PMID:
7591287
13.
14.

Heparin derivatives as angiogenesis inhibitors.

Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Liekens S, Rusnati M.

Curr Pharm Des. 2003;9(7):553-66. Review.

PMID:
12570803
15.

Heparin-steroid conjugates lacking glucocorticoid or mineralocorticoid activities inhibit the proliferation of vascular endothelial cells.

Derbyshire EJ, Yang YC, Li S, Comin GA, Belloir J, Thorpe PE.

Biochim Biophys Acta. 1996 Jan 10;1310(1):86-96.

PMID:
9244180
16.

Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice.

Thorpe PE, Derbyshire EJ, Andrade SP, Press N, Knowles PP, King S, Watson GJ, Yang YC, Rao-Betté M.

Cancer Res. 1993 Jul 1;53(13):3000-7.

17.

Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin.

Wilks JW, Scott PS, Vrba LK, Cocuzza JM.

Int J Radiat Biol. 1991 Jul-Aug;60(1-2):73-7. No abstract available.

PMID:
1713944
18.

Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.

Hori Y, Hu DE, Yasui K, Smither RL, Gresham GA, Fan TP.

Br J Pharmacol. 1996 Aug;118(7):1584-91.

19.
20.

Undersulfated and glycol-split heparins endowed with antiangiogenic activity.

Casu B, Guerrini M, Guglieri S, Naggi A, Perez M, Torri G, Cassinelli G, Ribatti D, Carminati P, Giannini G, Penco S, Pisano C, Belleri M, Rusnati M, Presta M.

J Med Chem. 2004 Feb 12;47(4):838-48.

PMID:
14761186
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk